Association between blood selenium level and nonalcoholic fatty liver disease among naturally menopausal women: A cross-sectional study
Open Access
- 13 March 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (11) , e48008
Abstract
Nonalcoholic fatty liver disease (NAFLD) is a growing health burden worldwide. The association between blood selenium (Se) and NAFLD in naturally menopausal women remains unclear. This study aimed to evaluate the association of blood Se levels with the prevalence of NAFLD, hepatic steatosis, and liver fibrosis in the US naturally menopausal women population. This study analyzed the dataset from the 2017 to 2018 National Health and Nutrition Examination Survey, including 595 naturally menopausal women. Weighted logistic regression models were used to evaluate the cross-sectional association between blood Se levels and the prevalence of NAFLD. Linear regression and ordinal logistic regression were used to evaluate the association between blood Se levels and liver steatosis and fibrosis. All analyses were conducted using the R survey package. There were no significant associations of blood Se levels with NAFLD in 3 adjusted models (odds ratio [OR] = 0.52, 95% confidence interval [CI], 0.04–7.11; OR = 0.66, 95% CI, 0.04–9.82; OR = 0.79, 95% CI, 0.08–8.08). However, in the fully adjusted model, blood Se levels showed a negative association with liver fibrosis (β = −2.32, 95% CI, −4.21, −0.43). Participants were divided into quartiles (Q1–Q4) based on the distribution of blood Se concentrations within the study cohort. The specific cutoff points were Q1 group (<173.67 μg/L), Q2 group (173.67 to <189.15 μg/L), Q3 group (189.15 to <204.35 μg/L), and Q4 group (≥204.35 μg/L). Compared with the reference group (Q1 group, <173.67 μg/L), significant inverse associations were also found for the higher Se groups (Q3 group: OR = 0.23, 95% CI, 0.1–0.53; Q4 group: OR = 0.28, 95% CI, 0.12–0.66). Our results showed that blood Se levels were not significantly associated with the prevalence of NAFLD in a US population of naturally menopausal women, but higher blood Se levels were negatively associated with liver fibrosis. Further research is needed to assess the causal relationship between exposure and disease risk.Keywords
This publication has 48 references indexed in Scilit:
- Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysiseClinicalMedicine, 2022
- Are there outcome differences between NAFLD and metabolic‐associated fatty liver disease?Hepatology, 2022
- Selenium stimulates the antitumour immunity: Insights to future researchEuropean Journal of Cancer, 2021
- Inverse Association of Telomere Length With Liver Disease and Mortality in the US PopulationHepatology Communications, 2021
- Prevalence of Fatty Liver Disease and Fibrosis Detected by Transient Elastography in Adults in the United States, 2017-2018Clinical Gastroenterology and Hepatology, 2021
- Selenium and selenoprotein P in nonalcoholic fatty liver diseaseHormones, 2019
- Zinc and Selenium Co-supplementation Reduces Some Lipid Peroxidation and Angiogenesis Markers in a Rat Model of NAFLD-Fed High Fat DietBiological Trace Element Research, 2017
- Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitisHepatology, 2013
- The Prevalence and Clinical Correlates of Nonalcoholic Fatty Liver Disease (NAFLD) in African Americans: The Multiethnic Study of Atherosclerosis (MESA)Digestive Diseases and Sciences, 2013
- Toxicity and chemical form of selenium in the liver of mice orally administered selenocystine for 90 daysArchives of Toxicology, 1994